Evidence map›Paper›PMID 39937575›Full record

ArticleeLife2025

SERBP1 interacts with PARP1 and is present in PARylation-dependent protein complexes regulating splicing, cell division, and ribosome biogenesis.

Kira Breunig, Xuifen Lei, Mauro Montalbano, Gabriela D A Guardia, Shiva Ostadrahimi, Victoria Alers, Adam Kosti, Jennifer Chiou, Nicole Klein, Corina Vinarov and 9 more

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Kira Breunig *Children's Cancer Research Institute, UT Health San Antonio, San Antonio, United States.
Xuifen Lei *Children's Cancer Research Institute, UT Health San Antonio, San Antonio, United States.ORCID https://orcid.org/0009-0000-1071-6190
Mauro Montalbano *Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, United States.ORCID https://orcid.org/0000-0002-0456-452X
Gabriela D A GuardiaCentro de Oncologia Molecular, Hospital Sírio-Libanês, São Paulo, Brazil.ORCID https://orcid.org/0000-0002-1789-2768
Shiva OstadrahimiChildren's Cancer Research Institute, UT Health San Antonio, San Antonio, United States.
Victoria AlersChildren's Cancer Research Institute, UT Health San Antonio, San Antonio, United States.
Adam KostiChildren's Cancer Research Institute, UT Health San Antonio, San Antonio, United States.
Jennifer ChiouDepartment of Nutritional Sciences, College of Natural Sciences, University of Texas at Austin, Austin, United States.
Nicole KleinChildren's Cancer Research Institute, UT Health San Antonio, San Antonio, United States.
Corina VinarovChildren's Cancer Research Institute, UT Health San Antonio, San Antonio, United States.
Lily WangChildren's Cancer Research Institute, UT Health San Antonio, San Antonio, United States.
Mujia LiChildren's Cancer Research Institute, UT Health San Antonio, San Antonio, United States.
Weidan SongLaboratory of Signaling and Gene Regulation, Cecil H. and Ida Green Center for Reproductive Biology Sciences,The University of Texas Southwestern Medical Center, Dallas, United States.
W Lee KrausLaboratory of Signaling and Gene Regulation, Cecil H. and Ida Green Center for Reproductive Biology Sciences,The University of Texas Southwestern Medical Center, Dallas, United States.ORCID https://orcid.org/0000-0002-8786-2986
David S LibichChildren's Cancer Research Institute, UT Health San Antonio, San Antonio, United States.ORCID https://orcid.org/0000-0001-6492-2803
Stefano TizianiDepartment of Nutritional Sciences, College of Natural Sciences, University of Texas at Austin, Austin, United States.
Susan T WeintraubDepartment of Biochemistry and Structural Biology, UT Health San Antonio, San Antonio, United States.ORCID https://orcid.org/0000-0002-8328-7814
Pedro A F GalanteCentro de Oncologia Molecular, Hospital Sírio-Libanês, São Paulo, Brazil.ORCID https://orcid.org/0000-0002-4820-4155
Luiz O PenalvaChildren's Cancer Research Institute, UT Health San Antonio, San Antonio, United States.ORCID https://orcid.org/0000-0003-4491-6769

Funding

TISSUE CULTURE---COREP30CA054174 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Lei Zheng · 1991 to 2026
$59.1M
The Role of PARP-1 in Hormone-Regulated TranscriptionR01DK069710 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI KRAUS, WILLIAM LEE · 2004 to 2025
$7.9M
Computational Methods for Deep Sequencing Based RBP Binding Motif CharacterizatioR01HG006015 · NHGRI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI PENALVA, LUIZ OTAVIO, SMITH, ANDREW DAVID · 2011 to 2017
$2.6M
Role of Transcription Factor ADP-ribosylation in Breast Cancer BiologyR01CA251943 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI KRAUS, WILLIAM LEE · 2021 to 2025
$2.0M
Alzheimer's Association AARF-21-720991Alzheimer's Association AARGD-NTF-22-968603Cancer Prevention and Research Institute of Texas RP200595Fundação de Amparo à Pesquisa do Estado de São Paulo 2017/19541-2Fundação de Amparo à Pesquisa do Estado de São Paulo 2018/15579-8Mays Cancer Center Pilot GrantNCI NIH HHS P30 CA054174NCI NIH HHS R01 CA251943NHGRI NIH HHS R01 HG006015NIDDK NIH HHS R01 DK069710NIH HHS 2R01 HG006015NIH HHS CA54174-23Voelker Fund Young Investigator Grant
6 · The paper itself

Abstract

RNA binding proteins (RBPs) containing intrinsically disordered regions (IDRs) are present in diverse molecular complexes where they function as dynamic regulators. Their characteristics promote liquid-liquid phase separation (LLPS) and the formation of membraneless organelles such as stress granules and nucleoli. IDR-RBPs are particularly relevant in the nervous system and their dysfunction is associated with neurodegenerative diseases and brain tumor development. Serpine1 mRNA-binding protein 1 (SERBP1) is a unique member of this group, being mostly disordered and lacking canonical RNA-binding domains. We defined SERBP1's interactome, uncovered novel roles in splicing, cell division and ribosomal biogenesis, and showed its participation in pathological stress granules and Tau aggregates in Alzheimer's brains. SERBP1 preferentially interacts with other G-quadruplex (G4) binders, implicated in different stages of gene expression, suggesting that G4 binding is a critical component of SERBP1 function in different settings. Similarly, we identified important associations between SERBP1 and PARP1/polyADP-ribosylation (PARylation). SERBP1 interacts with PARP1 and its associated factors and influences PARylation. Moreover, protein complexes in which SERBP1 participates contain mostly PARylated proteins and PAR binders. Based on these results, we propose a feedback regulatory model in which SERBP1 influences PARP1 function and PARylation, while PARylation modulates SERBP1 functions and participation in regulatory complexes.

Indexed as

Cell DivisionPoly (ADP-Ribose) Polymerase-1RibosomesRNA-Binding ProteinsRNA SplicingHumansProtein BindingPARP1 protein, humanPoly (ADP-Ribose) Polymerase-1RNA-Binding Proteinsalzheimer'sbiochemistrychemical biologygeneticsgenomicsglioblastomahumanPARP1proteomicsRNA binding proteinSERBP1

Identifiers

PMID39937575
PMCPMC11820137

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.